Netupitant-palonosetron to prevent chemotherapy-induced nausea and vomiting in multiple myeloma patients receiving high-dose melphalan and autologous stem cell transplantation.

Vincenzo ApolitoLuisa GiacconeSimone FerreroAlessandra LaroccaFederica CavalloMarta CosciaEloise BeggiatoSara ButeraFederica MartellaCristina DaineseGiusy CetaniMatilde ScaldaferriFrancesco CattelMario BoccadoroDario FerreroBenedetto BrunoMarco Cerrano

Published in: Annals of hematology (2020)

Keyphrases

chemotherapy induced
high dose
stem cell transplantation
multiple myeloma
low dose
bone marrow
cell therapy
platelet rich plasma
stem cells